Literature DB >> 19226362

Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome.

Katrien Devreese1, Marc F Hoylaerts.   

Abstract

The antiphospholipid antibody syndrome (APS) is defined by two major elements: the presence in plasma of auto-antibodies, i.e. antiphospholipid antibodies and the occurrence of clinical features, categorised as vascular thrombosis or pregnancy morbidity. In contrast to recent reviews on the physiopathology of APS, the present review focuses on the laboratory diagnosis of APS. The original clinical and laboratory criteria that defined patients with APS were set in 1998 in the so-called Sapporo criteria. Although a revision of these criteria was published in 2006, a number of questions on the laboratory diagnosis of APS remain unresolved. The highlight in this review will therefore be on the potential and limitations of the detection of the lupus anticoagulant, as an established laboratory criterion for the diagnosis of APS. The strengths and weaknesses of the current laboratory guidelines are discussed against our current insight in the physiopathology of APS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19226362     DOI: 10.1111/j.1600-0609.2009.01243.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  13 in total

1.  Detection of anticardiolipin antibody IgG by time-resolved fluoroimmunoassay.

Authors:  Yan Ye; Zhigang Hu; Jie Liu; Guoqian Chen; Yaohong Zhou; Lei Yu
Journal:  Clin Rheumatol       Date:  2012-06-10       Impact factor: 2.980

2.  A new Eu(3+)-labeled method for anticardiolipin antibody IgM.

Authors:  Yan Ye; Zhigang Hu; Jie Liu; Guoqian Chen; Yaohong Zhou
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

3.  Thrombophilic alterations, migraine, and vascular disease: results from a case-control study.

Authors:  Cinzia Cavestro; Diana Degan; Gianmatteo Micca; Raffaele Aloi; Silvia Mandrino; Maria Cristina Frigeri; Francesca Pistoia; Filippo Molinari; Simona Sacco
Journal:  Neurol Sci       Date:  2021-01-20       Impact factor: 3.307

Review 4.  Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.

Authors:  Savino Sciascia; Mary-Carmen Amigo; Dario Roccatello; Munther Khamashta
Journal:  Nat Rev Rheumatol       Date:  2017-08-03       Impact factor: 20.543

Review 5.  Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?

Authors:  Vittorio Pavoni; Lara Gianesello; Andrew Horton
Journal:  J Thromb Thrombolysis       Date:  2021-05-10       Impact factor: 2.300

6.  Characterization of antiphospholipid antibodies in chronic hepatitis B infection.

Authors:  Ji Young Huh; Dae Young Yi; Seong Gyu Hwang; Jin Jung Choi; Myung Seo Kang
Journal:  Korean J Hematol       Date:  2011-03-15

Review 7.  The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours?

Authors:  Emmanuel J Favaloro; Richard C W Wong
Journal:  Auto Immun Highlights       Date:  2010-07-10

Review 8.  "New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome.

Authors:  Roberta Misasi; Antonella Capozzi; Agostina Longo; Serena Recalchi; Emanuela Lococo; Cristiano Alessandri; Fabrizio Conti; Guido Valesini; Maurizio Sorice
Journal:  J Immunol Res       Date:  2015-03-19       Impact factor: 4.818

Review 9.  Thrombophilic disorders in migraine.

Authors:  Cinzia Cavestro; Silvia Mandrino
Journal:  Front Neurol       Date:  2014-07-10       Impact factor: 4.003

10.  Clinical Application of Revised Laboratory Classification Criteria for Antiphospholipid Antibody Syndrome: Is the Follow-Up Interval of 12 Weeks Instead of 6 Weeks Significantly Useful?

Authors:  Sang Hyuk Park; Seongsoo Jang; Chan-Jeoung Park; Hyun-Sook Chi
Journal:  Biomed Res Int       Date:  2016-08-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.